AI assistant
Replimune Group, Inc. — Director's Dealing 2022
Dec 6, 2022
33193_dirs_2022-12-05_7e53b8fe-de4e-4dcf-8c5d-68006a53911c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2022-12-01
Reporting Person: Xynos Konstantinos (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 37500 | Direct |
| Common Stock | 7000 | Direct |
| Common Stock | 8798 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $28.62 | 2031-11-29 | Common Stock (75000) | Direct | |
| Employee Stock Option (right to buy) | $18.26 | 2032-04-01 | Common Stock (10500) | Direct |
Footnotes
F1: Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person was granted 50,000 RSUs on November 29, 2021, 25% of such RSUs vested and were released on November 15, 2022, and the remainder will vest in three approximately equal annual installments thereafter until November 15, 2025, subject to the Reporting Person's continuous service to the Issuer.
F2: Represents shares of the Issuer's common stock issuable upon settlement of RSUs granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person was granted 7,000 RSUs on April 1, 2022, 25% of such RSUs vest on May 15, 2023, and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer.
F3: 25% of the shares underlying this stock option vested on November 29, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
F4: 25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.